Waverly Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$884K Sell
3,312
-366
-10% -$99.1K 0.01% 867
2025
Q4
$923K Buy
3,678
+419
+13% +$111K 0.01% 787
2025
Q3
$935K Buy
3,259
+172
+6% +$46.1K 0.01% 659
2025
Q2
$810K Buy
3,087
+67
+2% +$16.3K 0.01% 671
2025
Q1
$703K Sell
3,020
-182
-6% -$44.2K 0.01% 687
2024
Q4
$734K Sell
3,202
-40
-1% -$9.18K 0.01% 584
2024
Q3
$725K Sell
3,242
-11
-0.3% -$2.42K 0.01% 504
2024
Q2
$662K Buy
+3,253
New +$662K 0.01% 515

Other funds holding LH

Waverly Advisors's LH Position: Q1 2026 in Review

Waverly Advisors reduced its Labcorp (LH) stake by 10% in Q1 2026, selling an estimated $99.1K and leaving 3,312 shares worth $884K. The position accounts for 0.01% of the portfolio, ranked #867.

Waverly Advisors first reported a position in LH in Q2 2024 and has held it in 8 quarters since. The position peaked at $935K in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Waverly Advisors held 3,312 shares of Labcorp worth $884K as of Q1 2026.
  • Waverly Advisors sold 366 Labcorp shares in Q1 2026, an estimated $99.1K.
  • Labcorp made up 0.01% of Waverly Advisors's portfolio in Q1 2026, its #867 holding.
  • Waverly Advisors first reported a position in Labcorp in Q2 2024 and has held it in 8 quarters since.
  • Waverly Advisors's Labcorp position peaked at $935K in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Waverly Advisors's 13F filing for Q1 2026, filed 15 May 2026.